zirconium has been researched along with Colorectal Cancer in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (81.82) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Clark, DA; Cuda, TJ; Gough, M; He, Y; Hooper, JD; Khan, T; Kryza, T; Liu, C; Lyons, N; Puttick, S; Riddell, AD; Rose, S; Snell, CE; Sokolowski, KA; Stevenson, ARL; Thomas, PA; Tse, BW; Wyld, DK | 1 |
Bouvet, M; Fong, Y; Hong, T; Li, L; Lwin, TM; Minnix, M; Olafsen, T; Poku, E; Sherman, A; Shively, JE; Wong, JYC; Yazaki, PJ | 1 |
Ashiq, MN; Athar, M; Fatima, B; Hussain, D; Mohyuddin, A; Najam-Ul-Haq, M | 1 |
Boellaard, R; Huisman, MC; Lammertsma, AA; Makris, NE; Menke, CW; van Velden, FH | 1 |
Abdel-Atti, D; Aggeler, R; Agnew, BJ; Carlin, SD; Chen, A; Davis, CB; Lewis, JS; Zeglis, BM | 1 |
Bensch, F; Reyners, AK; Schröder, CP; van Rooijen, JM | 1 |
Hansen, AE; Hasenberg, M; Jensen, AI; Jørgensen, JT; Kjær, A; Maurer, A; Pichler, B; Rolle, AM; Severin, GW; Wiehr, S | 1 |
Boellaard, R; Huisman, MC; Lammertsma, AA; Makris, NE; Menke, CW; van Dongen, GA; van Lingen, A; Verheul, HM | 1 |
He, Z; Li, Y; Shi, G; Wang, G; Wang, H; Zhang, Q | 1 |
Boellaard, R; Gootjes, EC; Hoekstra, OS; Huisman, MC; Luik, AM; Menke-van der Houven van Oordt, CW; Mulder, ER; Roth, C; Schuit, RC; van Dongen, GA; Verheul, HM; Vugts, DJ | 1 |
Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK | 1 |
1 trial(s) available for zirconium and Colorectal Cancer
Article | Year |
---|---|
89Zr-cetuximab PET imaging in patients with advanced colorectal cancer.
Topics: Biomarkers, Tumor; Cetuximab; Colorectal Neoplasms; Disease Progression; ErbB Receptors; Humans; Molecular Targeted Therapy; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Treatment Outcome; Zirconium | 2015 |
10 other study(ies) available for zirconium and Colorectal Cancer
Article | Year |
---|---|
Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer.
Topics: Animals; Antigens, Neoplasm; Cell Adhesion Molecules; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; Heterografts; Humans; Ligands; Mice; Positron Emission Tomography Computed Tomography; Radioisotopes; Zirconium | 2021 |
Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Humans; Immunoconjugates; Mice; Polyethylene Glycols; Positron-Emission Tomography; Tissue Distribution; Zirconium | 2023 |
Gallic acid functionalized UiO-66 for the recovery of ribosylated metabolites from human urine samples.
Topics: Adsorption; Adult; Colorectal Neoplasms; Female; Gallic Acid; Humans; Male; Metal-Organic Frameworks; Middle Aged; Particle Size; Phthalic Acids; Porosity; Ribonucleosides; Zirconium | 2019 |
Validation of simplified dosimetry approaches in ⁸⁹Zr-PET/CT: the use of manual versus semi-automatic delineation methods to estimate organ absorbed doses.
Topics: Antibodies, Monoclonal, Humanized; Cetuximab; Colorectal Neoplasms; Humans; Kidney; Liver; Lung; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radioisotopes; Radiometry; Radiopharmaceuticals; Spleen; Time Factors; Tomography, X-Ray Computed; Zirconium | 2014 |
Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.
Topics: Animals; Colorectal Neoplasms; Electrophoresis, Polyacrylamide Gel; Fluorescent Dyes; Galactose; Humans; Immunoconjugates; Mice; Multimodal Imaging; Neoplasms, Experimental; Optical Imaging; Polysaccharides; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Xenograft Model Antitumor Assays; Zirconium | 2014 |
A 21-year-old patient with a HER2-positive colorectal cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Molecular Imaging; Organoplatinum Compounds; Oxaliplatin; Positron-Emission Tomography; Predictive Value of Tests; Radioisotopes; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab; Treatment Outcome; Young Adult; Zirconium | 2015 |
The impact of weakly bound ⁸⁹Zr on preclinical studies: non-specific accumulation in solid tumors and aspergillus infection.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Cell Line, Tumor; Colorectal Neoplasms; Female; Head and Neck Neoplasms; Humans; Hydrolysis; Ligands; Lung; Mice; Oxalic Acid; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Water; Zirconium | 2015 |
PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Marrow; Cetuximab; Colorectal Neoplasms; Female; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiation Dosage; Radioisotopes; Radiometry; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging; Zirconium | 2015 |
Controllable construction of titanium dioxide-zirconium dioxide@zinc hydroxyfluoride networks in micro-capillaries for bio-analysis.
Topics: Animals; Cattle; Colorectal Neoplasms; Electrophoresis, Capillary; Fluorides; Glass; Humans; Milk; Phosphopeptides; Silicon Dioxide; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Titanium; Zinc; Zirconium | 2015 |
PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Diagnostic Imaging; ErbB Receptors; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Panitumumab; Peritoneal Neoplasms; Positron-Emission Tomography; Protein Transport; Radiochemistry; Radioisotopes; Risk Assessment; Zirconium | 2012 |